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ABSTRACT 
Ethnobotanical plants have been used in the treatment of various diseases since antiquity. The phytoconstituents have 
pharmacological activities such as anti-tumor, anti-inflammatory, antinociceptive, anti-obesity, thermoregulatory effects, 
cardioprotective, anti-asthmatic, anti-diabetic, anti-oxidant, hepatoprotective and potent CNS activities. Various drug delivery 
systems like liposomes, niosomes, transferosomes, ethosomes, phytosomes, colloidosomes etc. are developed in order to carry the 
drug to the site of action without its metabolism. The major concern with respect to phytoconstituents having different chemical 
nature is its bioavailability and effective dosage concentration which could be overcome by means of phytosome technology. 
Chemically, phytosomes are vesicles of phospholipids bonded with a hydrogen bond to phytochemical/s. The current review 
highlights the major therapeutic applications of phytosomes till date. The review discusses about a latest and novel drug delivery 
system viz. “Phytosome technology” whereby major emphasis has been provided on the different therapeutic applications of 
phytosomes and its crucial role in managing the conventional complications that are encountered for the delivery of 
phytoconstituents. Applications of phytosomes such as enhancing bioavailability, anti-cancer and anti-oxidant agent, transdermal 
delivery, wound healing capacity etc. have been discussed. The comparison between the therapeutic activities of free drug and its 
phytosomes indicates that the complex provides various advantages over the conventional treatments.  
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INTRODUCTION: 
Over the last century, phyto-chemical science and 
phyto-pharmacological science established numerous 
plant compounds with various biological activities and 
health promoting benefits such as anti-mutagenicity, 
anti-carcinogenicity and anti-oxidative activity, for age-
related diseases namely memory loss, osteoporosis, 
diabetic wounds, immune and liver disorders, etc. 
Herbal medicines have been known since eons for their 
safety, efficacy, folk acceptability and fewer side 
effects. They are believed to have better compatibility 
with the human body since the chemical constituents 
present in them are a part of the physiological functions 
of living flora.
1,2,3
 
However, most of these biologically active constituents 
of plants show poor bioavailability owing to their large 
molecular size, comprising of multiple rings, which 
cannot be absorbed by passive diffusion, or due to their 
poor lipid solubility; severely limiting the ability to pass 
across the lipid‐rich biological membranes.4 
Drug delivery systems (DDS) are capable of designing 
drugs with increased bioavailability and controlled 
delivery by minimizing drug degradation or pre-
systemic metabolism of plant actives, also preventing 
the serious side effects resulting due to the accumulation 
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of drugs to the non-targeted areas. It improves the ease 
of administration of such difficult phytochemicals to 
assimilate drugs in the pediatric and geriatric patients.
4,5
 
Control of the distribution of drug, in this novel drug 
delivery technology, is achieved by incorporating the 
drug (plant actives) in carrier system or in changing the 
structure of the drug at molecular level. This mechanism 
aids in increasing solubility, stability, protection from 
toxicity, pharmacological activity, improved tissue 
macrophage distribution and sustained delivery. 
6
 
Novel drug delivery system encompasses different types 
of pharmaceutical carriers such as polymeric micelles, 
particulate systems, macro- and micromolecules. 
Particulate type carrier, also known as colloidal carrier 
system, includes lipid particles, micro- and 
nanoparticles, micro- and nanospheres, polymeric 
micelles, and vesicular systems like liposomes, 
sphingosomes, niosomes, transfersomes, aquasomes, 
ufasomes, and so forth. The vesicular systems are highly 
ordered assemblies of one or several concentric lipid 
bilayer formed, when certain amphiphillic building 
blocks are confronted with water. These systems 
contribute in prolonging the existence of the drug in 
systemic circulation, reducing toxicity and delaying 
elimination of rapidly metabolizable drugs.
7
 
Indena, an Italian pharmaceutical and nutraceutical 
company, first developed the complexation of plant 
extracts containing water-soluble constituents with 
phospholipids to improve their bioavailability. They 
patented the technology as ‘PHYTOSOME®’.8 The 
term “phyto” means plant and “some” means cell like. 
Due to the creation of an H- bond between 
phospholipids and the phytoconstituents, phytosomes  
show better physical stability, enhancing absorption of 
hydrophilic polar phytoconstituents resulting in 
enhanced bioavailability and greater therapeutic 
benefits.
9
 
Some phytoconstituents show more than one therapeutic 
activity, but also prove to be toxic at higher dosages. 
With the advent of phytosomes, it would rather alter its 
toxicity into effective aftermath even when used at high 
concentrations and thereby increasing its efficacy.
10
 
Phytosomes, commonly known as herbosomes, is a 
novel phytolipid formulation technology attempting to 
break through the barriers put forth by the conventional 
drug delivery systems with respect to bioavailability and 
stability of plant-derived drugs.  
With the advancements in science, the herbosomes have 
gained importance in various fields like 
pharmaceuticals, cosmeceuticals and nutraceuticals in 
preparing different formulations such as solutions, 
emulsion, creams, lotions, gels, etc. Products containing 
standardized polyphenolic extracts are now available in 
the market for clinical applications. Some of the popular 
ones include Casperome boswellia herbosome  for 
treating inflammatory conditions, Ginkgo select 
herbosome as cognition enhancer and as anti-oxidant, 
Hawthorn herbosome for cardiovascular health, 
Sericoside herbosome as anti-wrinkle and tonic and 
‘Meriva’ a curcumin herbosome for healthy joints. 
These herbosomes are significantly more bioavailable 
and hence therapeutically more effective than the 
standardized extracts or their conventional forms and are 
useful in various disorders. Several companies involved 
in production and marketing of herbosomal products are 
Indena, Jamieson natural resources, Thorne Research, 
Natural factors, and Natures herb
1
 
 
Figure 1: Diagrammatic representation of a phytosome 
In this review, we have tried to present the subject of 
phytosome technology through a single dimension 
whereby major emphasis has been provided on the 
different therapeutic applications of phytosomes, 
encompassing in detail, the crucial role, this invention 
has played in managing the complications earlier 
encountered during plant derived drug delivery. This 
review is aimed to provide a general insight towards the 
effective implementation of phytosome as means of 
treating cancer, enhancing bioavailability, wound 
healing agent etc.  
APPLICATIONS: 
1. Enhancing Bioavailability:  
Evodiamine, a quinoline alkaloid, (Evodia rutaecarpa) 
possess a multitude of pharmacological activities, such 
as anti-tumor, anti-inflammatory, anti-nociceptive, anti-
obesity, and thermoregulatory effects. Evodiamine has 
anti-tumor potential in a wide variety of tumor cells by 
inhibiting proliferation, inducing apoptosis and reducing 
invasion and metastasis. Phytosomes of Evodiamine 
proved to have higher in vitro dissolution rate, better 
absorption, longer action time and higher 
bioavailability. A prolonged action time and higher 
bioavailability was observed due to extended release of 
the drug from the phytosome. Moreover, these 
phytosomes might reduce the first-pass metabolism of 
Evodiamine by bypassing liver and therefore avoiding 
the direct contact of the drug with the hepatic 
metabolism enzymes. The bioavailability and T1/2 of 
Evodiamine was 1772.35 µg h
-1
 L
-1
and 1.33 hours 
respectively. And the enhanced bioavailability and T1/2 
with phytosome was 3787.24 µg h
-1
 L
-1
and 2.07 hours 
respectively. 
11
 
A European patent by ‘Indena S.P.A.’ relates to novel 
phospholipids complexes of olive fruits or leaf extracts 
having improved bioavailability. The Oleaselect 
phytosomes were synthesized using purified olive fruit 
extract possessing anti-hypertensive, diuretic, anti-
atherosclerotic, anti-oxidant and hypoglycemic 
properties, on account of its extensive phytochemical 
profile. The group treated with Oleaselect phytosomes 
showed a higher percentage of HT (hydroxytyrosol) and 
HVAlc (homovanillyl alcohol) indicating increase in 
oral bioavailability as compared to the group treated 
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with uncomplexed extract. A dose-related reduction of 
isoprostanes excretion was also observed. 
12
  
Ellagitannins belongs to a class of polyphenols which 
possess antioxidant mechanisms against cardiovascular 
disorders, cancers, and also wound healing, due to their 
antibacterial and anti-viral activities. The Papp (Apparent 
permeability) values for ellagitannins and its 
phytosomes by Everted gut sac technique were found to 
be 60 and 135 nm/s respectively. This showed that the 
apparent permeability of ellagitannins increased almost 
two times on complexation with Phosphatidylcholine.
13
 
The factors responsible for poor oral bioavailability of 
the phytoconstituents could be the dosage form, low 
concentrations available after chemical degradation, 
physical inactivation and elimination through the gut 
wall and liver. 
14
 However, the enhanced bioavailability 
of phytosomes administered through oral route is a 
result of increased hydrophilicity, solubility, decreased 
hepatic metabolism and enriched drug absorption in the 
systemic circulation.  
2. Antioxidant properties 
S. Moscarella et al 1993 studied the antioxidant and free 
radical scavenging activity of Silipide which is 
phytosome of Silybum marianum plant against liver 
oxidative damage induced by CC14 and paracetamol 
(high dosages) in rats. The mechanism by which Silipide 
protects hepatocytes against oxidative damage may be 
through inhibition of lipid peroxidation by scavenging 
reactive oxygen species. S. Moscarella et al 1993 
continued the studies on patients with Hepatitis B Virus 
and Hepatitis C Virus with Silipide for 2 months and 
determined that it remarkably reduced liver function 
parameters related to hepatocyte necrosis or increased 
cell membrane permeability. Serum Malondialdehyde 
levels of patients treated with silipide showed a 
remarkable reduction (36%) after 2 months of therapy 
suggesting that it possesses anti-lipoperoxidant activity 
against free radical attack in humans. 
15
 
A physically stable phytosomal formulation of 
Quercetin was prepared with higher encapsulation 
efficiency and physical stability to improve its efficacy 
in intestinal absorption and its preservation from 
oxidation in foodstuffs. 
16
 
One of the latest studies published in 2014 by B. Demir 
et al. 2014, talks about metal phytosome synthesized by 
encapsulation of extract of Calendula officinalis and its 
anti-oxidative effect. Reactive oxygen species analysis 
was performed using in vitro cell-based anti-oxidant 
assay on Vero cell lines. The outcome of this study 
depicted that the cell viability was approximately 35% 
and 81% of the plant extract and Au-loaded phytosome 
respectively.  
17
 
3. Hepato-Protective: 
The leaf extracts of Ginkgo biloba (Family: 
Ginkgoaceae) have been found to possess 
cardioprotective, anti-asthmatic, anti-diabetic, anti-
oxidant, hepatoprotective and potent CNS activities. The 
study demonstrated that phytosomes of G. biloba (200 
mg/kg) significantly alleviated isoproterenol-induced 
myocardial necrosis. Histopathological examination of 
the myocardium further confirmed the cardioprotective 
effects of phytosomes. Decreased myocardial necrosis 
(as evidenced by reduced AST, LDH and CPK release 
and histoarchitectural changes) and augmentation of 
endogenous antioxidants, all contribute to its 
cardioprotective effect.
18
 Literature also reveals that 
clinical hepatitis occurs in 1.1% of adults receiving 
Rifampicin treatment. S.R. Naik et al. 2008 investigated 
about the protective effects of Ginkgoselect 
Phytosome® on Rifampicin (RMP) induced 
hepatotoxicity and the probable mechanism(s) involved 
in this protection in rats. The present findings suggest 
that the hepatoprotective effect of Ginkgo select 
Phytosome® in RMP induced oxidative damage may be 
linked to its antioxidant and free radical scavenging 
activity. 
19
 
Mangiferin (MF) showed potent scavenging activity on 
Diphenyl-1-picrylhydrazyl (DPPH) radicals which 
stimulates liver regeneration in various liver injuries. Ex 
vivo study showed significant increased absorption of 
MF from MF herbosomes as compared to plain MF. The 
hepatoprotective potential of MF herbosomes evaluated 
by in vivo study revealed significantly decreased levels 
of serum glutamate oxaloacetate transminase (SGOT), 
serum glutamate pyruvate transaminase (SGPT), total 
bilirubin, and alkaline phosphatase (ALP) in MF 
herbosomes as compared to plain MF. MF herbosomes 
also showed significantly decreased level of malonyl 
dehydrogenase along with increased levels of reduced 
glutathione, superoxide dismutase (SOD) and catalase as 
compared to plain MF which was also comparable to the 
standard drug, Silymarin (SL). 
20
 
The traditional uses of Andrographolide (AN) obtained 
from Andrographis paniculata Linn include treatment of 
fever, inflammation, common cold, tonsilitis, 
pharyngitis, laryngitis, pneumonia, tuberculosis, 
pyelonephritis and hepatic impairment etc. The 
equimolar dose of drug shows lesser absorption and 
elevated levels of SGOT and SGPT in serum as 
compared to its phytosome dose indicating its 
hepatoprotective nature. 
21
 
4. Cancer treatment: 
The chemical components like flavones, isoflavones, 
flavonoids, anthocyanins, coumarins, lignins, catechins, 
and isocatechins of medicinal plants mainly possess 
antioxidant properties that contribute to their anticancer 
potential. However, a few plant-based compounds are 
toxic at higher concentrations and induce certain side 
effects. The already available expensive conventional 
therapies for cancer like chemotherapy and radiotherapy 
have a number of side effects such as myelosuppression 
and neurological, cardiac, pulmonary, and renal toxicity, 
which pose serious harm to the quality of life. 
22
 The 
entrapment of these plant derived drugs with the aid of 
bipolar moiety to enhance its solubility, dispersibility 
and permeability and thus prove to be a potent anti-
cancer agent.  
S. Shalini et al. 2015 researched on methanolic extract 
of Terminalia arjuna bark and its phytosome to 
investigate its antiproliferative activity on human breast 
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cancer cell line MCF-7 by MTT assay by comparing its 
activities with Quercetin and its phytosomes. The IC50 
values of the extract and its phytosome were 25μg/ml and 
15μg/ml respectively which suggests that they exert more 
antiproliferative effect as compared to free drug. 
23
 
D. Gallo et al. 2003 aimed to assess growth inhibitory 
effect of Silipide (Silybin complex) against human ovarian 
cancer (HOC) in vivo. The downregulation and 
upregulation of Vascular Endothelial Growth Factor 
(VEGF) and Angiopoietin-2 respectively indicates the anti-
angiogenic activity. HPLC analysis of free Silybin levels 
was found to be 7.0 mg/ml and 183.5 ng/g tissue in the 
plasma and tumor samples, respectively. No significant 
differences were seen in human VEGF levels in Silybin 
treated cells and vehicle blank. But a consistent decrease in 
VEGF concentration was observed in the tumor specimens 
treated with Silipide. The major finding of this study was to 
affirm Silipide as good candidate for the management of 
recurrent ovarian cancer. 
24
 
Narges Mahmoodi et al. 2014 worked with Silybin and its 
phytosomes to study the expression levels of estrogen 
receptor α (ERα) overexpressed in breast cancer, which is 
responsible for tumor growth enhancement, and is a 
prognostic and predictive factor. Silybin (silibinin) - 
(Silybum marianum) is a natural polyphenol with high 
antioxidant and anti-cancer properties which blocks VEGF, 
EGFR, COX-2 and TNF. The comparison of silybin and 
silybin-phosphatidylcholine by MTT assay indicates that 
all silybin-phosphatidylcholine doses had 2.5-3 times more 
inhibitory effect on cell growth than the same silybin doses 
in the T47D cell line. The results for 48 hours indicated all 
doses significantly down regulated ESR. (Erythrocyte 
sedimentation rate) 
25
 
M. Sabzichi et al. 2014 explored the previously studied role 
of Nrf2 (Nuclear factor erythroid 2-related factor 2) in 
resistance to chemotherapeutic agents in different types of 
cancer. In this study, M. Sabzichi et al. 2014, used Luteolin 
phytosomes to sensitize cancer cells MDA-MB 231cells 
(human breast cancer cell line) to chemotherapeutic agent 
Doxorubicin by downregulating the Nrf2 expression. The 
probable mechanism of action of Luteolin would be such 
that due to presence of Luteolin phytosomes the action of 
detoxifying enzymes and transporters could not act on 
Doxorubcin, as a result cells becomes sensitive to the 
drug.
26
 
5. Transdermal application 
Malay K Das et al. 2104, investigated about Rutin, one of 
the most common flavonoid (Ruta graveolens) used to treat 
capillary fragility, hypertension, ultraviolet radiation-
induced cutaneous oxidative stress, hepatic and blood 
cholesterol, cataract, cardiovascular disease and possesses 
antioxidant, anti-inflammatory, antithrombotic, 
antineoplastic, and antiplatelet activity. It was observed that 
the Rutin phytosomes were better able to penetrate the 
impermeable stratum corneum than its free form. Skin 
uptake of Rutin phytosomes was 33 ± 1.33 % whereas that 
of Rutin was 13 ± 0.87 %. 
27
 
The phytosomal complex of saponins and plant extracts 
(Panax ginseng M.) proved to be more active in vasal 
protection, capillary permeability, protection against UV 
radiation. Also helpful in preparation of dermatological and 
cosmetic pharmaceutical formulations, exhibiting 
moisturizing effect on the cutis making it more elastic due 
to a fibroblastic stimulation at the dermal level, with an 
increase in proteoglycan and collagen synthesis. The above 
mentioned compositions can in particular be used for oral 
administration in the form of tablets, capsules, syrups, 
granules, solutions (containing 1-500 mg dose of the 
complex) for treating conditions of inflammation, altered 
capillary fragility and permeability and, in general, in all 
the fields in which an activity of the saponins is recognized 
at present. 
28
  
6. Wound healing 
A. Mazumder et al. 2016 studied the wound healing activity 
of Sinigrin, one of the major glucosinolates occurring in the 
plant of Brassicaceae family, when evaluated as alone and 
as a phytosome complex on HaCaT cells. The sinigrin–
phytosome complex shows complete recovery of wound 
(100%) whereas the phytoconstituent alone displayed only 
71% healing. Moreover, sinigrin phytosomes also show 
enhanced anti-cancer activity on the A- 375 melanoma 
cells. 
10
 
S. Lakshmi Devi et al. 2012, researched on the comparative 
effects of ethanolic extracts of Wrightia arborea leaves and 
its phytosomes. The phytosomes exhibited about 90.40% 
healing while the ethanolic extract alone could heal only 
65.63% of the wound.
29
 As discussed earlier, the study of 
Demir et al. 2014, the formulated vesicles also exhibited 
enhanced wound healing activity (58.7 %) and penetration 
in the cells, accumulating around nucleus.
17
 
Limitations of phytosome: 
Phytosomes, despite of having numerous advantages as 
drug delivery system, are not prevalent in the market. 
Yamila B. Gándola et al. 2014,  mentioned that 
phospholipids (lecithin) can induce proliferation on MCF-7 
breast cancer cell line.
30
 A major drawback of phytosome 
could be leaching of the phytoconstituents off the ‘some’ 
which reduces the desired drug concentration indicating 
their unstable nature.  
CONCLUSION: 
An attempt was made to explore the ongoing research with 
respect to phytosomes and its applications such as wound 
healing, anti-oxidant, anti-cancer activities, etc. Phytosome 
technology proves to be efficient drug delivery system and 
has higher significance than the free drug. The information 
gathered herein will be useful for the researchers who wish 
to explore a vesicular drug delivery system which 
encompasses effective drug on target site without its 
metabolism. Phytosome technology should be explored for 
the treatment of other neurodegenerative, cardio-vascular 
and auto-immune diseases and skin-related disorders. 
Although, various phytosome products are available in the 
market, yet there are many other phytoconstituents which 
have remarkable ability to treat life threatening diseases, 
have not been implemented into phytosome technology.  
Further research can be done to develop highly target-
specific phytosomes.    
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